Compugen Ltd. (NASDAQ:CGEN) went down by -5.26% from its latest closing price compared to the recent 1-year high of $19.90. The company’s stock price has collected -1.10% of loss in the last five trading sessions. Press Release reported on 12/23/20 that Compugen Announces First Development Milestone in License Agreement with AstraZeneca for the Development of Bispecific and Multi-specific Antibody Products
Is It Worth Investing in Compugen Ltd. (NASDAQ :CGEN) Right Now?
Plus, the 36-month beta value for CGEN is at 2.44. Opinions of the stock are interesting as 6 analysts out of 7 who provided ratings for Compugen Ltd. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $21.43, which is $7.76 above the current price. CGEN currently public float of 82.38M and currently shorts hold a 5.70% ratio of that float. Today, the average trading volume of CGEN was 1.15M shares.
CGEN’s Market Performance
CGEN stocks went down by -1.10% for the week, with a monthly jump of 0.40% and a quarterly performance of -28.01%, while its annual performance rate touched 105.20%. The volatility ratio for the week stands at 6.29% while the volatility levels for the past 30 days are set at 7.73% for Compugen Ltd.. The simple moving average for the period of the last 20 days is -1.84% for CGEN stocks with a simple moving average of -12.23% for the last 200 days.
Analysts’ Opinion of CGEN
Many brokerage firms have already submitted their reports for CGEN stocks, with JMP Securities repeating the rating for CGEN by listing it as a “Mkt Outperform.” The predicted price for CGEN in the upcoming period, according to JMP Securities is $18 based on the research report published on May 26th of the previous year 2020.
Stifel, on the other hand, stated in their research note that they expect to see CGEN reach a price target of $19. The rating they have provided for CGEN stocks is “Buy” according to the report published on May 13th, 2020.
CGEN Trading at -2.49% from the 50-Day Moving Average
After a stumble in the market that brought CGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.58% of loss for the given period.
Volatility was left at 7.73%, however, over the last 30 days, the volatility rate increased by 6.29%, as shares surge +1.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.68% lower at present.
During the last 5 trading sessions, CGEN fell by -1.10%, which changed the moving average for the period of 200-days by +76.01% in comparison to the 20-day moving average, which settled at $12.86. In addition, Compugen Ltd. saw 4.21% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CGEN
The total capital return value is set at -72.98, while invested capital returns managed to touch -69.61. Equity return is now at value -27.00, with -23.30 for asset returns.
Based on Compugen Ltd. (CGEN), the company’s capital structure generated 9.34 points at debt to equity in total, while total debt to capital is 8.54. Total debt to assets is 6.66, with long-term debt to equity ratio resting at 7.77. Finally, the long-term debt to capital ratio is 7.11.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.60.